Our People

Wei Zhang

New York
(212) 259.7300
Wzhang@ckrlaw.com
vCard

BAR ADMISSIONS

State Bar of New York
State Bar of New Jersey


AREAS OF PRACTICE

Intellectual Property
Licensing and Technology Transfer
China Practice
IP Litigation
Blockchain Technology & Digital Currency


ACCREDITATIONS

Awards:
New York-Metro rising stars for intellectual property law by Super Lawyers (2014-2017)

EDUCATION

J.D. from Vanderbilt University Law School

M.S., Chemistry, University of Delaware

B.S., Biology, University of Science and Technology of China


LANGUAGES

English

Chinese

Wei Zhang is a partner in the New York City office. Mr. Zhang has a decade of experience in practicing intellectual property law. He has represented clients spanning from multinational corporations to start-ups in various industries, with a focus on the pharmaceutical and biotechnology fields.

Mr. Zhang advises clients on the management of global IP portfolios, including the freedom to operate, invalidity and non-infringement issues, as well as on various regulatory compliance matters. Some of the clients he has represented include Celgene Corp., Genentech, Inc., Boston Scientific Corp., and Purdue Pharma L.P.

Mr. Zhang also performs due diligence investigations in an acquisition, licensing, and technology transfer transactions, and drafts and negotiates commercial agreements. He represented a number of U.S. pharmaceutical companies in acquisitions of both privately held and publicly traded companies. He is also experienced in advising start-ups and investment funds in cross-border licensing and financing transactions.

In addition, Mr. Zhang has represented both U.S. and foreign clients in IP infringement actions and commercial disputes. Some representative matters include advising U.S. companies in invalidation and opposition proceedings in various countries and defending foreign corporations in patent infringement cases in the U.S.

Prior to joining CKR, Mr. Zhang worked at the New York office of a major international law firm. 

 

In the News: